Stay updated on Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial

Sign up to get notified when there's something new on the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.3%
    Check dated 2024-08-13T23:22:17.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    No Change Detected
  6. Check
    40 days ago
    Change Detected
    Summary
    The website has added new functionality for viewing and comparing study record versions in the latest update (v2.10.0), replacing the previous version (v2.9.7).
    Difference
    6%
    Check dated 2024-07-23T14:37:01.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.3%
    Check dated 2024-07-16T07:12:57.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.3%
    Check dated 2024-07-02T13:47:46.000Z thumbnail image
  9. Check
    66 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content or details of the webpage.
    Difference
    0.3%
    Check dated 2024-06-27T09:56:54.000Z thumbnail image
  10. Check
    67 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.3%
    Check dated 2024-06-26T08:51:15.000Z thumbnail image

Stay in the know with updates to Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fulvestrant + Neratinib in Breast Cancer (HER2-Signal) Clinical Trial page.